Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
French Avastin versus Lucentis Evaluation Group study
2008-003208-68Phase 3Active
- Sponsor
- Hospices Civils de Lyon
- Start
- Jun 2008
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of bevacizumab and ranibizumab in exudative macular degeneration (2 arms), sponsored by Hospices Civils de Lyon. Started Jun 2008; status: active.
02
Drugs
bevacizumabranibizumab
03
Conditions
exudative macular degeneration
Beyond the preview
Go deeper on 2008-003208-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003208-68.